Скачать или смотреть Advisory Committee on Immunization Practices (ACIP) - September 18, 2025 - Day 1 of 2

Major Update on Vaccination Policies Discussed at ACIP Meeting Amid Public Debate

September 18-19, 2025 — Washington, D.C. — The CDC’s Advisory Committee on Immunization Practices (ACIP) convened this week to review and discuss critical updates to childhood and adult vaccination guidelines, amid ongoing public debate about vaccine safety and policy.

During the meeting, a diverse panel of experts—including pharmacists, obstetricians, psychiatrists, immunologists, and public health officials—deliberated on topics ranging from the safety of the MMRV vaccine to the timing of hepatitis B vaccination at birth.

Key Highlights:

Vaccine Safety and Efficacy: Data reaffirmed the safety of vaccines like MMR, varicella, and hepatitis B, with discussions highlighting the rare but increased risk of febrile seizures following the first dose of MMRV, especially in children aged 12 to 15 months. The committee recognized the importance of transparent communication with parents about risks and benefits.

Vaccine Recommendations: The committee proposed new guidelines to restrict the use of combined MMRV vaccines before age four, favoring separate MMR and varicella shots to minimize adverse effects. These recommendations aim to balance vaccine efficacy with safety concerns, emphasizing parental choice and informed consent.

Hepatitis B Birth Dose Policy: The panel discussed the importance of administering the hepatitis B vaccine within 24 hours of birth for infants born to hepatitis B-negative mothers. Data from international studies support universal birth doses, but the U.S. continues to evaluate the best strategies, considering gaps in prenatal screening and healthcare access.

Public Trust and Transparency: A recurring theme was the need for open, science-driven debates and transparent sharing of data to maintain public confidence in vaccination programs. Some members expressed concern over misinformation and the politicization of vaccine science, urging for evidence-based policies.

Impact on Public Health: The committee emphasized that delaying or restricting certain vaccines could risk resurgence of preventable diseases like measles, mumps, rubella, and hepatitis B, which have seen significant declines due to vaccination efforts.

Next Steps:

The ACIP plans to vote on proposed recommendations, with an emphasis on ensuring that policies are grounded in robust scientific evidence and that they respect parental autonomy. Public comments are also solicited before final decisions are adopted.

As debates continue, health authorities reaffirm their commitment to science-based policies that protect public health while fostering trust and informed decision-making among communities.

#CDC #ACIP #Immunization #Vaccines #PublicHealth #MMRV #HepatitisBVaccine #COVID19Vaccine #VaccineRecommendations #HealthUpdates #VaccineSafety #ImmunizationGuidelines #PublicHealthUpdates #VaccinePolicy